Monteiro Hugo, Tavares Fernando, Reis João, Ferreira Gustavo, Campos M José, Costa Sérgio, Carvalho Laura, Carvalho João, Pedroto Isabel, Soares José, Henrique Rui, Bento Maria José, Hassan Cesare, Dinis-Ribeiro Mário
Departamento de Estudos e Planeamento. Administração Regional de Saúde do Norte. Porto. Portugal.
Agrupamento de Centros de Saúde de Maia e Valongo. Maia. Portugal.
Acta Med Port. 2022 Mar 2;35(3):164-169. doi: 10.20344/amp.15904. Epub 2021 Jul 20.
In Portugal, a colorectal cancer screening program based on faecal immunochemical test followed by colonoscopy was shown to be cost-effective for individuals between 50 and 74 years old. We report the first findings of the implementation of a population-based program In Northern Portugal.
In the pilot phase, eligible subjects were allocated either to a direct mailing invitation or to primary care centers. In the first year of program implementation, we assessed the uptake rate, the faecal immunochemical test -positivity rate, the diagnostic yield of advanced neoplasia, and the quality parameters for post-faecal immunochemical test + colonoscopy.
We invited 100 501 eligible subjects (49% male with a median age of 55 years). Of these, 5228 participated in the pilot phase and 95 273 participated in the first year of the program. In the first year of the program, the adherence was 29%, with a positivity rate of 5% and a 60% compliance to colonoscopy. The faecal immunochemical test-detection rate of advanced neoplasia was 0.35/1000 subjects, and the positive predictive value at post- faecal immunochemical test + colonoscopy was 44% and 2% for advanced adenoma and invasive cancer, respectively. No major adverse events were reported after colonoscopy.
The suboptimal adherence to faecal immunochemical test and post-faecal immunochemical test + colonoscopy remains the most urgent step to be addressed.
A centralized invitation system based on direct mailing was feasible and both colonoscopy quality and diagnostic yield were adequate antecipating the success of the programme.
在葡萄牙,一项基于粪便免疫化学检测随后进行结肠镜检查的结直肠癌筛查项目,已被证明对50至74岁的个体具有成本效益。我们报告了在葡萄牙北部实施的一项基于人群的项目的首批结果。
在试点阶段,符合条件的受试者被分配到直接邮寄邀请组或初级保健中心。在项目实施的第一年,我们评估了接受率、粪便免疫化学检测阳性率、晚期肿瘤的诊断率以及粪便免疫化学检测后结肠镜检查的质量参数。
我们邀请了100501名符合条件的受试者(49%为男性,中位年龄55岁)。其中,5228人参与了试点阶段,95273人参与了项目的第一年。在项目的第一年,依从率为29%,阳性率为5%,结肠镜检查的依从率为60%。粪便免疫化学检测对晚期肿瘤的检出率为0.35/1000名受试者,粪便免疫化学检测后结肠镜检查时,晚期腺瘤和浸润性癌的阳性预测值分别为44%和2%。结肠镜检查后未报告重大不良事件。
对粪便免疫化学检测以及粪便免疫化学检测后结肠镜检查的依从性欠佳,仍然是最亟待解决的问题。
基于直接邮寄的集中邀请系统是可行的,并且结肠镜检查质量和诊断率均足够,预示着该项目会取得成功。